Sectors

GRAL
GRAIL Inc.
69.95
45 x 70.09
1 x 71.11
bid
ask
+
2.08
3.06%
undefined @ 04:00 PM
70.09 +0.14 (0.20%)
Ytd-18.27%
1y115.70%
67.00
day range
71.25
29.95
52 week range
118.84
Open67.79Prev Close67.87Low67.00High71.25Mkt Cap3.00B
Vol776.09KAvg Vol704.65KEPS-9.75P/E-7.17Forward P/E-7.09
Beta3.25Short Ratio15.16Inst. Own86.89%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-0550-d Avg67.45200-d Avg73.671yr Est72.38

GRAL News

GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting
marketbeat.com
GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting

GRAIL NASDAQ: GRAL Chief Financial Officer Aaron Freidin said the company's Galleri multi-cancer ear

Bank of America Corp DE Purchases 205,611 Shares of GRAIL, Inc. $GRAL
defenseworld.net
Bank of America Corp DE Purchases 205,611 Shares of GRAIL, Inc. $GRAL

Bank of America Corp DE raised its holdings in shares of GRAIL, Inc. (NASDAQ: GRAL) by 29.0% during

GRAIL: Looking Beyond The NHS-Galleri Headline
seekingalpha.com
GRAIL: Looking Beyond The NHS-Galleri Headline

GRAIL faces a binary FDA approval event for Galleri, with significant stock movement expected based

FDA Panel Schedules to Evaluate GRAIL Premarket Approval Application for Multi-Cancer Early Detection Test
benzinga.com
FDA Panel Schedules to Evaluate GRAIL Premarket Approval Application for Multi-Cancer Early Detectio

GRAIL Inc. (NASDAQ:GRAL) on Friday said it is preparing for a pivotal regulatory event as the U.S. F

GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
gurufocus.com
GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Gall

GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Gall

US FDA to hold advisory meeting to review Grail's multi-cancer test
reuters.com
US FDA to hold advisory meeting to review Grail's multi-cancer test

Grail said on Friday the U.S. FDA ​plans to hold a ‌meeting of outside experts to review its multi-c

GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
prnewswire.com
GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Gall

MENLO PARK, Calif., Aug. 7, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company wh

GRAIL, Inc. (GRAL) Q2 2026 Earnings Call Transcript
seekingalpha.com
GRAIL, Inc. (GRAL) Q2 2026 Earnings Call Transcript

GRAIL, Inc. (GRAL) Q2 2026 Earnings Call Transcript

GRAIL Q2 Earnings Call Highlights
marketbeat.com
GRAIL Q2 Earnings Call Highlights

GRAIL NASDAQ: GRAL reported second-quarter revenue growth driven by higher Galleri test volumes, whi

GRAIL Reports Second Quarter 2026 Financial Results
prnewswire.com
GRAIL Reports Second Quarter 2026 Financial Results

Q2 Galleri ® Test Volume Increased 35% to More Than 61,000 Year-Over-Year, and Galleri Revenue Grew

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines – GRAL
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc.

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026
businesswire.com
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Cla

NEW YORK--(BUSINESS WIRE)---- $GRAL #ClassAction--Faruqi & Faruqi, LLP, a leading national securitie

Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
feeds.newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging In

New York, New York--(Newsfile Corp. - August 4, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nati

GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Securities Lawsuit - Contact The Gross Law Firm
prnewswire.com
GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Secur

NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholder

Portnoy Law Firm Announces Class Action on Behalf of Grail, Inc. Investors
globenewswire.com
Portnoy Law Firm Announces Class Action on Behalf of Grail, Inc. Investors

LOS ANGELES, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Grail, Inc., (“Grail” or

GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
gurufocus.com
GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Ac

GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Ac

GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
prnewswire.com
GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Ac

SAN FRANCISCO, Aug. 4, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GRAI

GRAL FINAL DEADLINE ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 4, 2026 Lead Plaintiff Deadline
globenewswire.com
GRAL FINAL DEADLINE ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Secu

SAN FRANCISCO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026
newsfilecorp.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging In

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogni

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
benzinga.com
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Wall Street analysts changed outlook on top stocks. See rating changes on NKE, SMPL, WSR, NTNX, and

Dow Rises Over 100 Points; US GDP Growth Slows In Q4
benzinga.com
Dow Rises Over 100 Points; US GDP Growth Slows In Q4

Earnings Scheduled For February 19, 2026
benzinga.com
Earnings Scheduled For February 19, 2026

Eagle Bancorp Posts Upbeat Q4 Results, Joins Corcept Therapeutics, LSI Industries And Other Big Stocks Moving Higher On Thursday
benzinga.com
Eagle Bancorp Posts Upbeat Q4 Results, Joins Corcept Therapeutics, LSI Industries And Other Big Stoc

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday
benzinga.com
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday

Earnings Scheduled For November 12, 2025
benzinga.com
Earnings Scheduled For November 12, 2025

benzinga.com
Earnings Scheduled For August 12, 2025

benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com
Earnings Scheduled For May 13, 2025

benzinga.com
Earnings Scheduled For February 20, 2025

benzinga.com
Earnings Scheduled For November 12, 2024